She signed up for a complicated clinical trial. It may cure her lupus
Summary
Sierra Butler, a teacher with severe lupus, joined a new clinical trial using CAR-T therapy, a treatment that changes a patient’s immune cells to fight disease. CAR-T, mostly used for cancer, is being tested to treat lupus by targeting the cells causing inflammation, offering hope to patients who do not respond to regular treatments.Key Facts
- Sierra Butler suffered from lupus, which damaged her heart and caused severe symptoms.
- She was hospitalized multiple times and required emergency heart surgery in 2020.
- Her regular lupus treatments were not working, leading to a referral to the Cleveland Clinic.
- Butler’s condition improved significantly with new drug treatments before joining the CAR-T therapy trial.
- CAR-T therapy involves changing a patient’s immune cells to attack harmful cells causing lupus.
- This therapy has shown success in early studies, with some patients achieving remission and stopping all medications.
- The treatment targets overactive B-cells responsible for inflammation in lupus patients.
- The therapy is experimental and part of a complex clinical trial with very few participants.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
